MAM
HRMY icon

Martingale Asset Management’s Harmony Biosciences HRMY Stock Holding History

Martingale Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
77,038
+7,696
+11% +$243K 0.07% 318
2026
Q1 		$1.94M Buy
69,342
+15,710
+29% +$515K 0.05% 354
2025
Q4 		$2.01M Buy
53,632
+2,203
+4% +$72.4K 0.05% 314
2025
Q3 		$1.42M Buy
51,429
+2,431
+5% +$83.7K 0.04% 404
2025
Q2 		$1.55M Buy
48,998
+3,286
+7% +$106K 0.04% 363
2025
Q1 		$1.52M Buy
45,712
+8,113
+22% +$291K 0.04% 368
2024
Q4 		$1.29M Buy
37,599
+2,816
+8% +$96.8K 0.03% 416
2024
Q3 		$1.39M Buy
34,783
+14,946
+75% +$525K 0.03% 396
2024
Q2 		$598K Buy
+19,837
New +$596K 0.01% 567
2023
Q4 		– Sell
-11,240
Closed -$368K – 814
2023
Q3 		$368K Hold
11,240
– – 0.01% 654
2023
Q2 		$396K Sell
11,240
-14,533
-56% -$502K 0.01% 655
2023
Q1 		$841K Hold
25,773
– – 0.02% 485
2022
Q4 		$1.42M Buy
25,773
+196
+0.8% +$10.8K 0.03% 351
2022
Q3 		$1.13M Buy
25,577
+4,755
+23% +$232K 0.02% 403
2022
Q2 		$1.02M Buy
20,822
+799
+4% +$36K 0.02% 462
2022
Q1 		$975K Buy
20,023
+3,302
+20% +$135K 0.01% 487
2021
Q4 		$713K Buy
+16,721
New +$666K 0.01% 566

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Martingale Asset Management's HRMY Position: Q2 2026 in Review

Martingale Asset Management increased its Harmony Biosciences (HRMY) stake by 11% in Q2 2026, buying an estimated $243K and bringing the position to 77,038 shares worth $2.8M. The position accounts for 0.07% of the portfolio, ranked #318.

Martingale Asset Management first reported a position in HRMY in Q4 2021 and has held it in 17 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Martingale Asset Management held 77,038 shares of Harmony Biosciences worth $2.8M as of Q2 2026.
  • Martingale Asset Management bought 7,696 Harmony Biosciences shares in Q2 2026, an estimated $243K.
  • Harmony Biosciences made up 0.07% of Martingale Asset Management's portfolio in Q2 2026, its #318 holding.
  • Martingale Asset Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 17 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.